This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.
CureMatch Articles & News
CureMatch will leverage mProbe’s targeted proteomics platform to assess individual proteins within patients’ tumor tissues. CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine support for oncology, is proud to announce a collaboration with mProbe Inc., a premier CLIA-certified targeted proteomics company. mProbe utilizes a proprietary technology platform integrating […]
Oncologists will be able to submit claims to payers using a Category III CPT code, paving the way for wider adoption of precision treatment options. CureMatch, Inc., a leader in precision medicine support for oncology, is pleased to announce that the American Medical Association (AMA) has issued the new Current Procedural Terminology (CPT®) Category III […]
Congratulations to CureMatch CEO Navid Alipour for being named a Top Leader of Influence in Life Science Top 50 Honoree by San Diego Business Journal. Alipour is a long-time entrepreneur in the AI space, founding multiple companies with an emphasis on the convergence of AI and the life sciences – a model now referred to […]
Dr. Link, Dr. Shlain and Mr. Simon all bring deep entrepreneurial experience in the medical and pharmaceutical fields to precision medicine. SAN DIEGO, CA, UNITED STATES, July 21, 2022 /EINPresswire.com/ — CureMatch, Inc., a leader in precision medicine support for oncology, announced today that John S. Link, MD, Jordan Shlain, MD and Greg Simon have […]